2023 IJGC Article Awards

Mario Preti, MD Department of Surgical Sciences, University of Torino, Torino, Italy Dr. Mario Preti is an Associate Professor of Gynecology and Obstetrics in the Department of Surgical Sciences at the University of Torino in Italy. He is currently Chair of the Lower Female Genital Tract Unit at the University of Torino. Author of 130 indexed papers, Dr. Preti has been a member of the ESGO Prevention Committee since 2020 and served as the President of the ISSVD from 2017-2019.

Giorgio Bogani, MD, PhD Department of Gynecologic Surgery Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy Giorgio Bogani works in the Department of Gynecologic Surgery at the Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan (Italy). In 2013 he received his research fellowship at the Gynecologic Unit of the Mayo Clinic (Rochester, MN). In 2021, Dr Bogani achieved the title of associate professor from the University “La Sapienza” of Rome. He has been honored with awards for his academic excellence by several societies, including the European Society of Gynaecological Oncology (ESGO), the European Society for Gynaecological Endoscopy (ESGE), and the International Society of Gynecological Endocrinology (ISGE). His areas of interest include gynecologic oncology, precision medicine, as well as targeted therapies. @BoganiGiorgio

Prof. Giovanni Scambia Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica del Sacro Cuore, Rome, Italy Professor Giovanni Scambia is specialized in gynaecological cancer treatment and research. He has studied and developed innovative surgical approaches for the cure of gynaecological cancers and has been invited professor in several academic hospitals both in Europe and outside Europe. He is considered an opinion leader in the field of gynecologic oncology. @scambiagiovanni

Dr. Catherine Connolly Consultant Histopathologist working with the Gynaecologic Oncology team in St James’s Hospital Dublin Dr Catherine Connolly is a graduate of Trinity College Dublin, Ireland. She undertook her histopathology specialist training in Ireland before moving to Toronto, Canada for Fellowship training in Perinatal Pathology and Gynaecologic Pathology. Catherine is currently a Consultant Histopathologist working with the Gynaecologic Oncology team in St James’s Hospital Dublin.

Emma R. Allanson CGO, PhD Queensland Centre for Gynaecological Cancer, Royal Brisbane and Women's Hospital, Brisbane Queensland, Australia Associate Professor Emma Allanson is a gynaecological oncologist at King Edward Memorial Hospital in Perth, Western Australia. She completed her gynaecological oncology fellowship in Australia, in addition to a research fellowship at MD Anderson Cancer Center, and an editorial fellowship with the International Journal of Gynecological Cancer. She has a PhD in women's health in low- and middle-income countries, and her research interests are focused on the prevention and treatment of cervical cancer. @emmaallanson

Frédéric Amant Md PhD UZ Leuven, Belgium Frédéric Amant (MD, PhD) is a specialist at University Hospitals Leuven (Belgium) and the Netherlands Cancer Institute (NKI, the Netherlands). He is professor at KU Leuven and at the University of Amsterdam (UvA, the Netherlands) and honorary professor at the University of Pretoria (South Africa). Frédéric Amant heads the Gynecologic Oncology research sections at KU Leuven and the NKI. He founded and chairs the ‘International Network on Cancer, Infertility and Pregnancy (INCIP)’. In 2021, he launched the Advisory Board on Cancer, Infertility and Pregnancy (ABCIP). At KU Leuven, Frédéric Amant founded Trace, a tumor xenograft platform and the Fund for Innovative Research. He also co-founded ENITEC, the European Network on Individualized Treatment of Endometrial Cancer. @AmantLab

Félix Boria Alegre, MD, PhD Clínica Universidad de Navarra, Madrid, Spain Félix Boria is a gynecologic oncologist currently working at Clinica Universidad de Navarra, under the mentorship of Dr. Luis Chiva. He completed the IJGC editorial fellowship in 2022. @BoriaFelix

Robert L. Coleman, MD US Oncology, Texas Oncology Dr. Coleman completed his Obstetrics & Gynecology residency at Northwestern University Medical Center in Chicago, Illinois, and completed his fellowship at The University of Texas MD Anderson Cancer Center in 1993. He held faculty positions at Creighton University School of Medicine, The University of Texas, Southwestern, where he served as Vice-Chairman, Department of Obstetrics and Gynecology, and M.D. Anderson Cancer center, where he served as Professor and Executive Director for Cancer Network Research, holding the Ann Rife Cox Chair in Gynecology. In March 2020, he joined US Oncology Research (USOR) as their Chief Scientific Officer and currently serves as Chief Medical Officer for Vaniam Group. Dr. Coleman has authored or coauthored over 700 scientific publications, including over 410 peer-reviewed articles, along with numerous book chapters, monographs, invited articles, and textbooks. He is the immediate Past-President of the International Gynecologic Cancer Society (IGCS). @rcoledude

Mikel Gorostidi, MD, MS Hospital Universitario Donostia Basque Country, Spain Dr. Mikel Gorostidi received his medical training at the University of Navarra 1998. He is currently working at the Donostia University Hospital in San Sebastian, in the gynecologic oncology section, 3rd level center with centralization of complex oncology. He is on the faculty of masters and surgical training in advanced endoscopy and oncology. Dr. Gorostidi has authored numerous publications (for IJGC, JMIG, Gynecology Oncology, Lancet Oncology, Annals of Surgical Oncology), served as a reviewer (for IJGC, JMIG & Frontiers in Oncology), and is currently on the editorial board of JMIG. He is an Associate Professor at the University of the Basque Country, and he is passionate about sports, traveling and his family. @mgorostidi

Christianne Anne Rachel Lok, MD, PhD Center for Gynecologic Oncology Amsterdam Dr. Christianne Lok is a gynecologic oncologist of the department of gynecologic oncology of the Center for Gynecologic Oncology, Amsterdam since 2013. She is trained in minimally invasive surgery including robotic surgery and also focuses on cytoreductive surgery. Her scientific research work delves into biomarkers for ovarian cancer and into the development of peritoneal metastases in ovarian cancer. Her clinical and research interests also include Gestational Trophoblastic Disease (GTD) and she is the chair of the Dutch Working Party on Trophoblastic Disease and past president of the European Organization for the Treatment of Trophoblastic Disease (EOTTD). She is also actively involved in the care and research on Cancer & Pregnancy. She is the chair of the Dutch Advisory Board on Cancer in pregnancy and actively involved in the international advisory board on cancer in pregnancy (ABCIP) and international Network for Cancer in Pregnancy (INCIP).

Ainhoa Madariaga, MD Hospital Universitario 12 de Octubre Dr. Ainhoa Madariaga is a Medical Oncologist in the Gynecologic Cancer Unit at 12 de Octubre University Hospital in Madrid, Spain. She is the chair of the Young and Early Career Investigator - EORTC Gynecological Cancer Group. Her research interests include patient reported outcomes and drug development. @AinhoaMada

Florencia Noll, MD Sanatorio Allende, Cordoba, Argentina Florencia Noll is a Gynecologic Oncologist currently working as an Assistant Professor in the Gynecologic Oncology Department at Sanatorio Allende Cerro, Cordoba City. She completed her Fellowship Program at The Hospital Italiano de Buenos Aires, Argentina, and the Editorial fellowship in the International Journal of Gynecological Cancer where she is currently part of the Early Career Editorial board and a regular peer reviewer. Dr. Noll authored and co-authored over 24 scientific publications, and she also participates monthly on the Board for the ECHO Virtual Tumor project. Her uppermost clinical and research interests include health care, disease prevention, and treatment for patients with gynecologic cancer. @FlorenciaNoll

Prof. Giovanni Scambia Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome Professor Giovanni Scambia is specialized in gynaecological cancer treatment and research. He has studied and developed innovative surgical approaches for the cure of gynaecological cancers and has been an invited professor in several academic hospitals both in Europe and outside Europe. He is considered an opinion leader in the field of gynecologic oncology. @scambiagiovanni

Irina Tsibulak Medical University of Innsbruck, Austria and Kliniken Essen Mitte, Germany Irina Tsibulak completed her residency at the Medical University of Innsbruck, Austria and was one of the IJGC editorial fellows in 2021. After a traveling fellowship at the Imperial College of London, she is currently completing the ESGO fellowship at Kliniken Essen Mitte, Germany. Her main areas of interest are ERAS implementation, as well as biomarkers, targeted therapies and individualized surgical approach in ovarian cancer. @irinatsibulak